Choksi Laboratories Share Price | Choksi Laboratories Stock Screener
CHOKSILA
Healthcare Service Provider
Share Price BSE
₹112.80
▲
0.05 (0.04%)
As of July 24, 2026, the Choksi Laboratories share price (BSE: CHOKSILA) is ₹112.80, up 0.04% from the previous close, with shares trading between ₹112.80 and ₹112.85, and a 52-week range of ₹89.65–₹228.05.
Analyse CHOKSILA share price charts and track historical price performance.
Use the Choksi Laboratories stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Choksi Laboratories Market Cap
₹76.59 Cr.
CHOKSILA P/E Ratio (TTM)
37.94
Choksi Laboratories P/B Ratio
2.91
EPS (TTM)
₹2.82
Dividend Yield
-
Debt to Equity
1.31
CHOKSILA 52 Week High
₹228.05
Choksi Laboratories 52 Week Low
₹89.65
Operating Margin
26.00%
Profit Margin
4.35%
CHOKSILA Revenue (TTM)
₹46.00
EBITDA
₹12.00
Net Income
₹2.00
Total Assets
₹72.00
Total Equity
₹26.00
Choksi Laboratories Share Price Chart
Screen Choksi Laboratories share price with an interactive chart. Analyse CHOKSILA price trends and volatility across different timeframes.
Choksi Laboratories Company Profile - Fundamental Screener
Screen Choksi Laboratories company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for CHOKSILA shares.
Sector
Healthcare Services
Industry
Healthcare Service Provider
Sub-Sector
Healthcare Service Provider
Segment
E
ISIN
INE493D01013
Choksi Laboratories Balance Sheet Screener
Screen CHOKSILA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 72 | 65 | 62 | 60 | 64 | 66 | 65 | 55 | 45 | 41 |
| Current Assets | 19 | 16 | 15 | 14 | 14 | 13 | 17 | 16 | 15 | 13 |
| Fixed Assets | 52 | 48 | 43 | 45 | 47 | 50 | 33 | 35 | 29 | 22 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 23 | 18 | 21 | 27 | 31 | 32 | 30 | 18 | 7 | 5 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 26 | 24 | 22 | 21 | 18 | 18 | 20 | 24 | 22 | 21 |
| Share Capital | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
| Reserves & Surplus | 19 | 17 | 15 | 14 | 11 | 11 | 13 | 17 | 15 | 14 |
Choksi Laboratories Income Statement Screener - Profit & Revenue Analysis
Screen Choksi Laboratories income statement and profit fundamentals.
Analyze CHOKSILA quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Choksi Laboratories share price evaluation.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 46 | 42 | 37 | 35 | 30 | 26 | 29 | 34 | 31 | 30 | 22 | 23 |
| Expenses | 34 | 31 | 27 | 24 | 21 | 22 | 25 | 27 | 24 | 24 | 17 | 17 |
| EBITDA | 12 | 11 | 10 | 11 | 9 | 5 | 3 | 8 | 7 | 6 | 5 | 6 |
| Operating Profit % | 26.00% | 27.00% | 28.00% | 30.00% | 30.00% | 16.00% | 10.00% | 22.00% | 21.00% | 17.00% | 23.00% | 23.00% |
| Depreciation | 7 | 7 | 6 | 6 | 5 | 5 | 5 | 4 | 3 | 3 | 3 | 3 |
| Interest | 3 | 3 | 3 | 4 | 3 | 3 | 2 | 2 | 2 | 2 | 1 | 2 |
| Profit Before Tax | 3 | 2 | 2 | 4 | 0 | -3 | -6 | 2 | 2 | 1 | 1 | 1 |
| Tax | 1 | 1 | 1 | 1 | 0 | 0 | -2 | 1 | 1 | 0 | 0 | 1 |
| Net Profit | 2 | 2 | 1 | 3 | 0 | -3 | -4 | 2 | 1 | 1 | 1 | 1 |
| EPS | 2.82 | 2.19 | 1.59 | 4.61 | 0.30 | -3.74 | -5.58 | 2.30 | 1.93 | 1.28 | 1.04 | 1.27 |
Choksi Laboratories Cash Flow Screener - Liquidity Fundamentals
Screen CHOKSILA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 12 | 12 | 8 | 8 | 6 | 3 | 7 | 6 | 7 | 0 |
| Investing Activities | -8 | -7 | -1 | -3 | -8 | -14 | -10 | -5 | -2 | 0 |
| Financing Activities | -4 | -5 | -8 | -5 | 2 | 11 | 2 | -1 | -5 | 0 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 0 | 0 | 0 |
Choksi Laboratories Shareholding Pattern Screener
See Choksi Laboratories shareholding pattern with promoter, FII, and DII holdings.
Check Choksi Laboratories promoter holding and ownership changes for CHOKSILA on TickJournal.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 31.48% | 31.48% | 31.48% | 31.48% | 31.48% | 31.48% | 31.48% | 31.48% |
| FII Holding | 6.03% | 7.02% | 1.94% | 4.31% | 5.69% | 5.69% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 49.44% | 49.42% | 52.67% | 49.58% | 48.77% | 49.07% | 60.01% | 60.70% |
| Other Holding | 13.05% | 12.08% | 13.92% | 14.63% | 14.05% | 13.76% | 8.51% | 7.82% |
| Shareholder Count | 4,011 | 3,945 | 4,162 | 4,167 | 4,067 | 4,057 | 4,187 | 4,051 |
Choksi Laboratories Share Dividend Screener - Share Yield Analysis
Check Choksi Laboratories dividend history with payout and yield data.
View Choksi Laboratories dividend details including ex-dates and amounts for CHOKSILA stock.
Choksi Laboratories Stock Index Membership
See which indices include Choksi Laboratories stock.
Check CHOKSILA index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Choksi Laboratories Market Events Screener - Corporate Actions
Get Choksi Laboratories corporate actions including splits, bonuses, and buybacks.
Check Choksi Laboratories stock events that may affect CHOKSILA share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-05-25 | 2026-05-25 | Quarterly Result Announcement | NA | 27.88% |
| 2026-02-07 | 2026-02-07 | Quarterly Result Announcement | NA | -3.31% |
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | -5.25% |
| 2025-09-16 | 2025-09-16 | Annual General Meeting | NA | -12.03% |
| 2025-08-13 | 2025-08-13 | Quarterly Result Announcement | NA | 14.87% |
| 2025-06-07 | 2025-06-07 | Quarterly Result Announcement | NA | 28.65% |
| 2025-05-29 | 2025-05-29 | Quarterly Result Announcement | NA | -0.27% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | 0.44% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | 9.28% |
| 2024-09-21 | 2024-09-21 | Annual General Meeting | NA | 13.51% |
Choksi Laboratories Competitors Screener - Peer Comparison
Screen CHOKSILA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Dr. Lal Path Labs | 28,386 | 55.45 | 2,864 | 12.11% | 510 | 54.82 |
| Vijaya Diagnostic Centre | 13,734 | 79.78 | 814 | 16.36% | 182 | 48.92 |
| Metropolis Healthcare | 11,895 | 59.35 | 1,646 | 22.25% | 185 | 56.90 |
| Thyrocare Technologies | 8,842 | 50.85 | 846 | 20.48% | 163 | 58.11 |
| Nephrocare Health Services | 6,309 | 83.20 | 999 | 29.74% | 62 | 39.80 |
| Krsnaa Diagnostics | 1,773 | 17.33 | 773 | 4.05% | 106 | 48.50 |
| Suraksha Diagnostic | 1,344 | 42.90 | 310 | 21.30% | 34 | 36.41 |
| One Global Service Provider | 1,157 | 16.95 | 498 | 237.06% | 69 | 46.50 |
| 3B BlackBio DX | 1,088 | 17.90 | 142 | 27.17% | 61 | 58.05 |
| Health X Platform | 1,012 | -706.67 | 1,319 | 12.68% | -3 | 50.98 |
Choksi Laboratories Company Announcements - News Screener
Screen CHOKSILA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-07-06 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-06-26 | Closure of Trading Window | - |
| 2026-05-26 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-25 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-05-25 | Result For The Quarter And Year Ended 31.03.2026 | - |
| 2026-05-25 | Board Meeting Outcome for Meeting Of Board Of Directors Held On 25.05.2026 | - |
| 2026-05-19 | Clarification On Email Dated 19Th May 2026 By BSE | - |
| 2026-05-18 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-05-18 | Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO) | - |
| 2026-05-18 | Board Meeting Outcome for Outcome For Meeting Of Board Of Directors Held On 18Th May 2026 | - |
| 2026-05-16 | Board Meeting Intimation for Meeting Of Board Of Directors To Be Held On 25.05.2026 | - |
| 2026-05-13 | Board Meeting Intimation for Meeting Of Board Of Director To Be Held On 18Th May 2026 | - |
| 2026-04-28 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | - |
| 2026-04-28 | Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot | - |
| 2026-04-15 | Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A | - |
| 2026-04-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-03-27 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-03-26 | Closure of Trading Window | - |
| 2026-03-26 | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot | - |
| 2026-02-09 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |